ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
ABSTRACT SARS-CoV-2 infection causing the COVID-19 pandemic calls for immediate interventions to avoid viral transmission, disease progression, and subsequent excessive inflammation and tissue destruction. Primary normal human bronchial epithelial cells are among the first targets of SARS-CoV-2 infe...
Main Authors: | W. Posch, J. Vosper, V. Zaderer, A. Noureen, S. Constant, R. Bellmann-Weiler, C. Lass-Flörl, D. Wilflingseder |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-04-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.00904-21 |
Similar Items
-
ColdZyme® protects airway epithelia from infection with BA.4/5
by: Zaderer Viktoria, et al.
Published: (2022-10-01) -
Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
by: Viktoria Zaderer, et al.
Published: (2023-01-01) -
Behind the Scenes of PluriZyme Designs
by: Ana Robles-Martín, et al.
Published: (2024-01-01) -
Design and Characterization of In-One Protease-Esterase PluriZyme
by: Laura Fernandez-Lopez, et al.
Published: (2022-11-01) -
Enhanced alcohol degradation and hepatic protective effects of an Acetobacter Pasteurianus-derived product, CureZyme-ACE, in an acute intoxication rat model
by: Eun-Jong Jeon, et al.
Published: (2020-06-01)